The Institute of Living is a comprehensive psychiatric facility in Hartford, Connecticut, that offers care across the spectrum of psychiatric services, including: A 24/7 crisis evaluation telephone ...

During the past decade, Institute of Living/Hartford Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 15 clinical trials were completed, i.e. on average, 78.9% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Living/Hartford Hospital" #1 sponsor was "Hartford Hospital" with 8 trials, followed by "Pfizer" with 4 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored, "Boston University Charles River Campus" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Living/Hartford Hospital" #1 collaborator was "National Institute of Mental Health (NIMH)" with 7 trials as a collaborator, "Hartford Hospital" with 3 trials as a collaborator, "American Foundation for Suicide Prevention" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cognitive Research Corporation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Living/Hartford Hospital" are "Schizophrenia" (7 trials), "Major Depressive Disorder" (5 trials), "Obsessive-Compulsive Disorder" (4 trials), "Depressive Disorder, Major" (3 trials) and "Panic Disorder" (3 trials). Many other conditions were trialed in "Institute of Living/Hartford Hospital" in a lesser frequency.

Most popular intervention types in "Institute of Living/Hartford Hospital" are "Drug" (22 trials), "Behavioral" (15 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Cognitive Behavioral Therapy" (3 trials), "Antidepressant + Placebo" (1 trials), "Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg" (1 trials) and "Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 30 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Living/Hartford Hospital" are 40 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institute of Living/Hartford Hospital". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 22 completed trials in Institute of Living/Hartford Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Living/Hartford Hospital, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".

Institute of Living/Hartford Hospital has several departments that took part in Clinical trials: "Olin Neuropsychiatry Research Center" - 5 trials, "Anxiety Disorders Center, Institute of Living" - 2 trials